<?xml version="1.0" encoding="UTF-8"?>
<collection xmlns="http://www.loc.gov/MARC21/slim">
 <record>
  <leader>     caa a22        4500</leader>
  <controlfield tag="001">397573383</controlfield>
  <controlfield tag="003">CHVBK</controlfield>
  <controlfield tag="005">20180308164847.0</controlfield>
  <controlfield tag="007">cr unu---uuuuu</controlfield>
  <controlfield tag="008">161202e199609  xx      s     000 0 eng  </controlfield>
  <datafield tag="024" ind1="7" ind2="0">
   <subfield code="a">10.1093/hmg/5.Supplement_1.1431</subfield>
   <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="035" ind1=" " ind2=" ">
   <subfield code="a">(NATIONALLICENCE)oxford-10.1093/hmg/5.Supplement_1.1431</subfield>
  </datafield>
  <datafield tag="245" ind1="0" ind2="0">
   <subfield code="a">Huntington disease: new insights into the relationship between CAG expansion and disease</subfield>
   <subfield code="h">[Elektronische Daten]</subfield>
   <subfield code="c">[Jamal Nasir, Y. Paul Goldberg, Michael R. Hayden]</subfield>
  </datafield>
  <datafield tag="520" ind1="3" ind2=" ">
   <subfield code="a">The mutation underlying Huntington disease (HD) is CAG expansion beyond 35 repeats within a novel gene. Recently, new insights into the role of the HD protein (huntingtin) in the pathogenesis of HD have emerged. The CAG is translated and expression of mutant huntingtin is essential for neuronal death. Huntingtin is crucial for normal development and may be regarded as a cell survival gene. Huntingtin is specifically cleaved during apoptosis by a key cysteine protease, apopain, known to play a pivotal role in apoptotic cell death. The rate of cleavage is enhanced by longer polyglutamine tracts, suggesting that inappropriate apoptosis underlies HD. Recently, three proteins have been identified and have been shown specifically to interact with huntingtin, two of these interactions being influenced by CAG length. Several different approaches to develop an animal model for HD include cDNA and YAC transgenics, as well as ‘knock-in' strategies. Such a model will be critical for the understanding of the natural history of HD and for the testing of new therapeutic modalities.</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
   <subfield code="a">© 1996 Oxford University Press</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Nasir</subfield>
   <subfield code="D">Jamal</subfield>
   <subfield code="u">Department of Medical Genetics and the Centre for Molecular Medicine and Therapeutics, University of British Columbia, 416-2125 East Mall, NCE Building, Vancouver, BC, V6T 1Z4, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Goldberg</subfield>
   <subfield code="D">Y. Paul</subfield>
   <subfield code="u">Department of Medical Genetics and the Centre for Molecular Medicine and Therapeutics, University of British Columbia, 416-2125 East Mall, NCE Building, Vancouver, BC, V6T 1Z4, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="700" ind1="1" ind2=" ">
   <subfield code="a">Hayden</subfield>
   <subfield code="D">Michael R.</subfield>
   <subfield code="u">Department of Medical Genetics and the Centre for Molecular Medicine and Therapeutics, University of British Columbia, 416-2125 East Mall, NCE Building, Vancouver, BC, V6T 1Z4, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="773" ind1="0" ind2=" ">
   <subfield code="t">Human Molecular Genetics</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">5/Supplement_1(1996-09), 1431-1435</subfield>
   <subfield code="x">0964-6906</subfield>
   <subfield code="q">5:Supplement_1&lt;1431</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">5</subfield>
   <subfield code="o">hmg</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2="0">
   <subfield code="u">https://doi.org/10.1093/hmg/5.Supplement_1.1431</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="908" ind1=" " ind2=" ">
   <subfield code="D">1</subfield>
   <subfield code="a">research-article</subfield>
   <subfield code="2">jats</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">856</subfield>
   <subfield code="E">40</subfield>
   <subfield code="u">https://doi.org/10.1093/hmg/5.Supplement_1.1431</subfield>
   <subfield code="q">text/html</subfield>
   <subfield code="z">Onlinezugriff via DOI</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Nasir</subfield>
   <subfield code="D">Jamal</subfield>
   <subfield code="u">Department of Medical Genetics and the Centre for Molecular Medicine and Therapeutics, University of British Columbia, 416-2125 East Mall, NCE Building, Vancouver, BC, V6T 1Z4, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Goldberg</subfield>
   <subfield code="D">Y. Paul</subfield>
   <subfield code="u">Department of Medical Genetics and the Centre for Molecular Medicine and Therapeutics, University of British Columbia, 416-2125 East Mall, NCE Building, Vancouver, BC, V6T 1Z4, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">700</subfield>
   <subfield code="E">1-</subfield>
   <subfield code="a">Hayden</subfield>
   <subfield code="D">Michael R.</subfield>
   <subfield code="u">Department of Medical Genetics and the Centre for Molecular Medicine and Therapeutics, University of British Columbia, 416-2125 East Mall, NCE Building, Vancouver, BC, V6T 1Z4, Canada</subfield>
   <subfield code="4">aut</subfield>
  </datafield>
  <datafield tag="950" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="P">773</subfield>
   <subfield code="E">0-</subfield>
   <subfield code="t">Human Molecular Genetics</subfield>
   <subfield code="d">Oxford University Press</subfield>
   <subfield code="g">5/Supplement_1(1996-09), 1431-1435</subfield>
   <subfield code="x">0964-6906</subfield>
   <subfield code="q">5:Supplement_1&lt;1431</subfield>
   <subfield code="1">1996</subfield>
   <subfield code="2">5</subfield>
   <subfield code="o">hmg</subfield>
  </datafield>
  <datafield tag="900" ind1=" " ind2="7">
   <subfield code="a">Metadata rights reserved</subfield>
   <subfield code="b">CC BY-NC-4.0</subfield>
   <subfield code="u">http://creativecommons.org/licenses/by-nc/4.0</subfield>
   <subfield code="2">nationallicence</subfield>
  </datafield>
  <datafield tag="898" ind1=" " ind2=" ">
   <subfield code="a">BK010053</subfield>
   <subfield code="b">XK010053</subfield>
   <subfield code="c">XK010000</subfield>
  </datafield>
  <datafield tag="949" ind1=" " ind2=" ">
   <subfield code="B">NATIONALLICENCE</subfield>
   <subfield code="F">NATIONALLICENCE</subfield>
   <subfield code="b">NL-oxford</subfield>
  </datafield>
 </record>
</collection>
